These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7790627)

  • 1. Task difficulty and cognitive deficits in schizophrenia.
    Miller MB; Chapman JP; Chapman LJ; Collins J
    J Abnorm Psychol; 1995 May; 104(2):251-8. PubMed ID: 7790627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence of systematic attenuation in the measurement of cognitive deficits in schizophrenia.
    Thomas ML; Patt VM; Bismark A; Sprock J; Tarasenko M; Light GA; Brown GG
    J Abnorm Psychol; 2017 Apr; 126(3):312-324. PubMed ID: 28277736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The selective attention deficit in schizophrenia. Limited resources or cognitive fatigue?
    Everett J; Laplante L; Thomas J
    J Nerv Ment Dis; 1989 Dec; 177(12):735-8. PubMed ID: 2574228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Schizophrenic subjects show deficient inhibition but intact task switching on saccadic tasks.
    Manoach DS; Lindgren KA; Cherkasova MV; Goff DC; Halpern EF; Intriligator J; Barton JJ
    Biol Psychiatry; 2002 May; 51(10):816-26. PubMed ID: 12007456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insight controlled for cognition in deficit and nondeficit schizophrenia.
    Dantas CR; Barros BR; Fernandes PT; Li LM; Banzato CE
    Schizophr Res; 2011 May; 128(1-3):124-6. PubMed ID: 21353484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Task difficulty moderates the revelation effect.
    Aßfalg A; Currie D; Bernstein DM
    Mem Cognit; 2017 May; 45(4):664-676. PubMed ID: 28028780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pre-reflective indicator of an impaired sense of agency in patients with Schizophrenia.
    Bulot V; Thomas P; Delevoye-Turrell Y
    Exp Brain Res; 2007 Oct; 183(1):115-26. PubMed ID: 17619866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurocognitive deficits or stress overload: Why do individuals with schizophrenia show poor performance in neurocognitive tests?
    Krkovic K; Moritz S; Lincoln TM
    Schizophr Res; 2017 May; 183():151-156. PubMed ID: 27838097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of varying the rate of presentation on the information transmission of schizophrenic and control groups.
    Wijesinghe OB
    Br J Psychiatry; 1977 May; 130():509-13. PubMed ID: 861433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain activation during executive processes in schizophrenia.
    Royer A; Schneider FC; Grosselin A; Pellet J; Barral FG; Laurent B; Brouillet D; Lang F
    Psychiatry Res; 2009 Sep; 173(3):170-6. PubMed ID: 19643585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subjective cognitive dysfunction in first-episode and chronic schizophrenic patients.
    Moritz S; Lambert M; Andresen B; Böthern A; Naber D; Krausz M
    Compr Psychiatry; 2001; 42(3):213-6. PubMed ID: 11349240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous performance test and schizophrenia: a test of stimulus-response compatibility, working memory, response readiness, or none of the above?
    Elvevåg B; Weinberger DR; Suter JC; Goldberg TE
    Am J Psychiatry; 2000 May; 157(5):772-80. PubMed ID: 10784471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabis abuse is associated with decision-making impairment among first-episode patients with schizophrenia-spectrum psychosis.
    Mata I; Rodríguez-Sánchez JM; Pelayo-Terán JM; Pérez-Iglesias R; González-Blanch C; Ramírez-Bonilla M; Martínez-García O; Vázquez-Barquero JL; Crespo-Facorro B
    Psychol Med; 2008 Sep; 38(9):1257-66. PubMed ID: 18005495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Executive functioning in schizophrenia: the result of impairments in lower order cognitive skills?
    Neill E; Rossell SL
    Schizophr Res; 2013 Oct; 150(1):76-80. PubMed ID: 23973320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Visual information processing deficits as biomarkers of vulnerability to schizophrenia: an event-related potential study in schizotypy.
    Koychev I; El-Deredy W; Haenschel C; Deakin JF
    Neuropsychologia; 2010 Jun; 48(7):2205-14. PubMed ID: 20412812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of peripheral levels of chemokines, BDNF and oxidative markers on cognition in individuals with schizophrenia.
    Asevedo E; Gadelha A; Noto C; Mansur RB; Zugman A; Belangero SI; Berberian AA; Scarpato BS; Leclerc E; Teixeira AL; Gama CS; Bressan RA; Brietzke E
    J Psychiatr Res; 2013 Oct; 47(10):1376-82. PubMed ID: 23806580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Schizophrenic deficits in the processing of context. A test of a theoretical model.
    Servan-Schreiber D; Cohen JD; Steingard S
    Arch Gen Psychiatry; 1996 Dec; 53(12):1105-12. PubMed ID: 8956676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cognitive deficit and schizophrenia].
    Torres A; Méndez L; Olivares JM; Vaamonde A
    Actas Esp Psiquiatr; 2001; 29(1):1-9. PubMed ID: 11333512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using negative feedback to guide behavior: impairments on the first 4 cards of the Wisconsin Card Sorting Test predict negative symptoms of schizophrenia.
    Vogel SJ; Strauss GP; Allen DN
    Schizophr Res; 2013 Dec; 151(1-3):97-101. PubMed ID: 24210530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive mapping deficits in schizophrenia: Evidence from clinical correlates of visuospatial transformations.
    Agarwal SM; Danivas V; Amaresha AC; Shivakumar V; Kalmady SV; Bose A; Narayanaswamy JC; Venkatasubramanian G
    Psychiatry Res; 2015 Aug; 228(3):304-11. PubMed ID: 26162664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.